BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9155670)

  • 1. Non-specifically labelled cells that simulate bone marrow metastases in patients with non-metastatic breast cancer.
    Lagrange M; Ferrero JM; Lagrange JL; Machiavello JC; Monticelli J; Bayle C; Creisson A; Namer M; Thyss A; Bourcier C; Gioanni J; Schneider M
    J Clin Pathol; 1997 Mar; 50(3):206-11. PubMed ID: 9155670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical staining of bone marrow biopsies for detection of occult metastasis in breast cancer.
    Mathieu MC; Friedman S; Bosq J; Caillou B; Spielmann M; Travagli JP; Contesso G
    Breast Cancer Res Treat; 1990 Jan; 15(1):21-6. PubMed ID: 2328327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow micrometastases in breast cancer patients.
    Molino A; Pelosi G; Micciolo R; Turazza M; Nortilli R; Pavanel F; Cetto GL
    Breast Cancer Res Treat; 1999 Nov; 58(2):123-30. PubMed ID: 10674876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence of bone marrow micrometastases in patients receiving adjuvant therapy for breast cancer: results at 4 years.
    Slade MJ; Singh A; Smith BM; Tripuraneni G; Hall E; Peckitt C; Fox S; Graham H; Lüchtenborg M; Sinnett HD; Cross NC; Coombes RC
    Int J Cancer; 2005 Mar; 114(1):94-100. PubMed ID: 15523696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of bone marrow micrometastases in patients with gastric cancer.
    Jauch KW; Heiss MM; Gruetzner U; Funke I; Pantel K; Babic R; Eissner HJ; Riethmueller G; Schildberg FW
    J Clin Oncol; 1996 Jun; 14(6):1810-7. PubMed ID: 8656249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disseminated tumor cells in bone marrow of patients with transitional cell carcinoma: immunocytochemical detection and correlation with established prognostic indicators.
    Hofmann T; Riesenberg R; Buchner A; Zimmermann W; Hofstetter A; Oberneder R
    J Urol; 2003 Apr; 169(4):1303-7. PubMed ID: 12629348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The influence of the hemoglobin concentration on the hematogenous tumor cell dissemination at the time of the initial diagnosis of breast cancer].
    Janni W; Strobl B; Rack B; Rjosk D; Schindlbeck C; Hantschmann P; Kentenich C; Sigg W; Zerzer M; Sommer H
    Dtsch Med Wochenschr; 2002 Jan; 127(3):71-7. PubMed ID: 11797143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of bone marrow involvement in breast cancer with magnetic resonance imaging.
    Sanal SM; Flickinger FW; Caudell MJ; Sherry RM
    J Clin Oncol; 1994 Jul; 12(7):1415-21. PubMed ID: 8021732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow micrometastases in 109 breast cancer patients: correlations with clinical and pathological features and prognosis.
    Molino A; Pelosi G; Turazza M; Sperotto L; Bonetti A; Nortilli R; Fattovich G; Alaimo C; Piubello Q; Pavanel F; Micciolo R; Cetto GL
    Breast Cancer Res Treat; 1997 Jan; 42(1):23-30. PubMed ID: 9116315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of micrometastasis to the bone marrow and lymph nodes of node-negative breast cancer patients receiving no adjuvant therapy.
    Braun S; Cevatli BS; Assemi C; Janni W; Kentenich CR; Schindlbeck C; Rjosk D; Hepp F
    J Clin Oncol; 2001 Mar; 19(5):1468-75. PubMed ID: 11230493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of disseminated carcinoma cells in bone marrow and peripheral blood in primary breast cancer with RT/PCR of parathyroid hormone-related protein (PTHrP)].
    Liersch T; Gatzemeier W; Scharnberg P; Jürgens B; Wörmann B; Becker H; Rauschecker HF; Hiddemann W; Wulf GG
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):277-80. PubMed ID: 14518259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection of disseminated tumor cells in bone marrow--currently of no practical therapeutic value].
    Ditsch N; Funke I; Mayer B; Untch M
    MMW Fortschr Med; 2002 Oct; 144(41):37-9. PubMed ID: 12474359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow immunoscintigraphy for the detection of skeletal metastases in patients with breast cancer.
    Lacić M; Bokulić T; Lukac J; Kovacić K; Baum RP; Kusić Z
    Nucl Med Commun; 1999 Feb; 20(2):135-43. PubMed ID: 10088162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative microvessel area of the primary tumour, and not lymph node status, predicts the presence of bone marrow micrometastases detected by reverse transcriptase polymerase chain reaction in patients with clinically non-metastatic breast cancer.
    Benoy IH; Salgado R; Elst H; Van Dam P; Weyler J; Van Marck E; Scharpé S; Vermeulen PB; Dirix LY
    Breast Cancer Res; 2005; 7(2):R210-9. PubMed ID: 15743502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential immunochemotherapy and edrecolomab in the adjuvant therapy of breast cancer: reduction of 17-1A-positive disseminated tumour cells.
    Kirchner EM; Gerhards R; Voigtmann R
    Ann Oncol; 2002 Jul; 13(7):1044-8. PubMed ID: 12176782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detection of disseminated tumor cells in the bone marrow of breast cancer patients with a new molecular method].
    Banyś M; Krawczyk N; Becker S; Becker-Pergola G; Banyś J; Krawczyk Z; Wallwiener D; Fehm T
    Ginekol Pol; 2012 Aug; 83(8):590-7. PubMed ID: 23342882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Micrometastases in axillary lymph nodes and bone marrow of lymph node-negative breast cancer patients--prognostic relevance after 10 years.
    Gebauer G; Fehm T; Merkle E; Jaeger W; Mitze M
    Anticancer Res; 2003; 23(5b):4319-24. PubMed ID: 14666645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype.
    Balic M; Lin H; Young L; Hawes D; Giuliano A; McNamara G; Datar RH; Cote RJ
    Clin Cancer Res; 2006 Oct; 12(19):5615-21. PubMed ID: 17020963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastatic bone marrow tumours: a report of six cases and review of the literature.
    Sar R; Aydogdu I; Ozen S; Sevinc A; Buyukberber S
    Haematologia (Budap); 2001; 31(3):215-23. PubMed ID: 11855783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ErbB2 overexpression on occult metastatic cells in bone marrow predicts poor clinical outcome of stage I-III breast cancer patients.
    Braun S; Schlimok G; Heumos I; Schaller G; Riethdorf L; Riethmüller G; Pantel K
    Cancer Res; 2001 Mar; 61(5):1890-5. PubMed ID: 11280743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.